SCHEMBL19935671

SCHEMBL19935671

Ic1nccc2[nH]cnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.44
EGLN1 Q9GZT9 1/20 0.41
CSNK2A1 P68400 2/20 0.39
CSNK2A2 P19784 1/20 0.39
LMNA P02545 2/20 0.38
PARP1 P09874 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 2/20 0.35
PRNP P04156 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DRD1 P21728 1/20 0.35
DPP4 P27487 1/20 0.34
PKM P14618 1/20 0.34
PNP P00491 1/20 0.32
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12304499 0.74 LMNA (0.46) MMP12EGLN1LMNAPARP1MEN1
SCHEMBL18301417 0.74 MMP12 (0.51) MMP12EGLN1CSNK2A1CSNK2A2LMNA
SCHEMBL2059241 0.74 EGLN1 (0.45) MMP12EGLN1CSNK2A1LMNAPARP1
SCHEMBL4563575 0.74 MMP12 (0.44) MMP12EGLN1LMNAPARP1MEN1
SCHEMBL563514 0.74 MMP12 (0.44) MMP12EGLN1LMNAPARP1MEN1
SCHEMBL29424896 0.74 EGLN1 (0.45) MMP12EGLN1CSNK2A1LMNAPARP1
SCHEMBL130593 0.74 MMP12 (0.44) MMP12EGLN1LMNAPARP1MEN1
Hydrochloric Acid SCHEMBL5088042 0.72 MMP12 (0.42) MMP12EGLN1LMNAPARP1MEN1
Hydrochloric Acid SCHEMBL21872987 0.72 EGLN1 (0.44) MMP12EGLN1CSNK2A1LMNAPARP1
Hydrochloric Acid SCHEMBL3713796 0.72 MMP12 (0.42) MMP12EGLN1LMNAPARP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026829-A1 PROCESS FOR PREPARING N-[[5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINYL]CARBONYL]-GLYCINE FROM 5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINE CARBOXYLIC ACID Akebia Therapeutics Inc. (US) 2022-07-13 EP disclosed
WO-2022135365-A1 DISUBSTITUTED CYCLOPENTANE KINASE INHIBITORS ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) 2022-06-30 WO disclosed
EP-3683209-A1 PROCESS FOR PREPARING [(5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ACETIC ACID FROM 5-((3-CHLOROPHENYL)-3-CHLORO-PYRIDIN-2-YL)-NITRILE, AND PROCESS FOR PREPARING 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES Akebia Therapeutics Inc. (US) 2020-07-22 EP disclosed
EP-3290404-A1 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES AS INTERMEDIATES IN THE PREPARATION OF [(5-(HALOPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ALKANOIC ACID DERIVATIVES Akebia Therapeutics Inc. (US) 2018-03-07 EP disclosed